The malignant microenvironment in early cutaneous T-cell lymphoma
The malignant microenvironment in early cutaneous T-cell lymphoma
批准号:
10459519
负责人:
Neda Nikbakht
金额:
$7.8万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-08-01 至 2024-07-31
关键词:
Alternative SplicingAnti-Inflammatory AgentsBindingBiologyBone MarrowCD4 Positive T LymphocytesCellsCutaneous LymphomaCutaneous T-cell lymphomaCytokine GeneDataDevelopmentEnvironmentExposure toExtracellular MatrixFibronectinsFosteringGene ExpressionGrowthHumanImmuneImmunityImmunocompetentImmunosuppressionIn SituIn VitroLesionLigandsMalignant - descriptorMalignant NeoplasmsMediatingMorbidity - disease rateMusMutationMyeloid CellsNatural ImmunityOutcomePathway interactionsPatientsPattern recognition receptorPhenotypeProtein IsoformsRNA SplicingRecombinantsReproducibilityRoleSignal TransductionSiteSkinT-LymphocyteTLR4 geneTestingTumor-associated macrophagesVariantWorkbasecytokineimmunosuppressive macrophagesimprovedinhibitormacrophagemonocytemortalitymouse modelnovel therapeutic interventionnull mutationreceptorskin lesionsmall moleculetumortumor growthtumor microenvironmenttumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
How the skin microenvironment contributes to proliferation of malignant CD4+ T cells in
cutaneous T-cell lymphoma (CTCL) is not well understood. We and others show that
immunosuppressive macrophages are present in CTCL lesional skin and express Toll
Like Receptor-4 (TLR4), signaling through which modifies macrophage phenotype and
function. We also find that fibronectin, a major component of the skin extracellular matrix
(ECM) is aberrantly expressed in CTCL skin in the form of an alternatively spliced
isoform EDA, a ligand for TLR4. Here we use an optimized immune competent murine
model for CTCL to study malignant CTCL microenvironment. We propose to investigate
two interrelated aims in this setting. 1) Determine the role of the TLR4-EDA pathway on
CTCL tumor growth and 2) Determine the impact of TLR4-EDA signaling on
macrophage phenotype and function. This work will provide valuable information on the
interplay between ECM dysregulation and tumor immunosuppression in CTCL and may
improve understanding of macrophage mediated immune suppression in general.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fmed.2023.1243459
发表时间:
2023
期刊:
FRONTIERS IN MEDICINE
影响因子:
3.9
作者:
[Bhatti, Safiyyah, Joffe, Daniel, Banner, Lauren, Talasila, Sahithi, Mandel, Jenna, Lee, Jason, Porcu, Pierluigi, Nikbakht, Neda]
通讯作者:
Nikbakht, Neda
DOI:
10.1016/j.jdermsci.2022.03.005
发表时间:
2022-04
期刊:
JOURNAL OF DERMATOLOGICAL SCIENCE
影响因子:
4.6
作者:
[Beksac, Burcu, Gleason, Laura, Baik, Sarah, Ringe, John M., Porcu, Pierluigi, Nikbakht, Neda]
通讯作者:
Nikbakht, Neda
Neutrophilic panniculitis associated with myelodysplastic syndrome/myeloproliferative neoplasm: a case report and literature review.
与骨髓增生异常综合征/骨髓增生性肿瘤相关的中性粒细胞性脂膜炎:病例报告和文献综述。
DOI:
10.1097/jd9.0000000000000286
发表时间:
2023
期刊:
International journal of dermatology and venereology
影响因子:
--
作者:
[Cohen,AlexaJ, Gleason,LauraK, Bhatti,SafiyyahA, Nikbakht,Neda]
通讯作者:
Nikbakht,Neda
The malignant microenvironment in early cutaneous T-cell lymphoma
-
批准号:10290730
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2021
-
负责人:Neda Nikbakht
-
依托单位:
Role of BAFF in regulation of B cell peripheral tolerance
-
批准号:8332944
-
项目类别:
-
资助金额:$4.17万
-
财政年份:2011
-
负责人:Neda Nikbakht
-
依托单位:
Role of BAFF in regulation of B cell peripheral tolerance
-
批准号:8061222
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2011
-
负责人:Neda Nikbakht
-
依托单位:
海外基金